The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.
The Canadian Network for Psychedelic-Assisted Cancer Therapy launches a systematic research program to study psychedelic assisted therapy cancer patients experiencing demoralization syndrome. This multi-phase initiative prioritizes training, safety…
Amrit Baral: Cannabis and Psychedelic Use Among Older U.S. Cancer Survivors
Psychedelic use older cancer survivors is an emerging area of clinical interest. This article provides estimates that inform screening and safety considerations. Understanding these patterns helps optimize symptom management in older cancer survivors.
Tilray Stock Eyes Breakout Week Amid Trump’s Cannabis Order
Tilray stock breakout week is gaining attention due to Trump's cannabis order, which opens new opportunities in the US cancer market. This policy shift may enhance medical cannabis market access. Patients and clinicians should watch for impacts on…
Emerging Cannabis-Related Colorectal Cancer Treatment Research
Cannabis-related colorectal cancer treatment is currently being tested in clinical trials in West Michigan. This emerging research focuses on potential therapeutic effects and symptom management. Clinicians await peer-reviewed data to evaluate its…
Cannabidiol Drug Interactions: Clinical Evidence Review
Cannabidiol drug interactions clinical evidence highlights CBD's potential to interact with multiple drug classes, especially opioids. Careful medication review is essential before starting CBD in patients on complex regimens. Clinicians should treat CBD…
